Annual report [Section 13 and 15(d), not S-K Item 405]

Geographic and segmental information (Tables)

v3.25.1
Geographic and segmental information (Tables)
12 Months Ended
Dec. 31, 2024
Geographic and segmental information  
Schedule of long-lived assets

Long-lived assets (excluding intangibles, deferred tax and financial instruments) were located as follows (in thousands):

December 31, 

December 31, 

    

2024

    

2023

U.K.

$

24,264

$

40,988

U.S.

 

26,954

 

30,720

Total long-lived assets

$

51,218

$

71,708

Summary of the segment profit or loss

Year ended

December 31, 

2024

    

2023

2022

Revenue

$

178,032

$

60,281

$

27,148

Less:

Research

(13,404)

(13,228)

(22,912)

CMC and Quality

(61,350)

(60,466)

(61,850)

Biomarkers

(8,227)

(4,235)

(8,977)

Development and Compliance

(52,737)

(43,863)

(43,614)

Infrastructure management and Facilities

(31,739)

(28,481)

(25,266)

Commercial and Commercial planning

(15,860)

(3,344)

(4,329)

Support and corporate functions

(45,186)

(43,614)

(32,483)

Other segment expenses(a)

(18,289)

(2,791)

8,318

Total operating expenses

(246,792)

(200,022)

(191,113)

Operating loss

(68,760)

(139,741)

(163,965)

Interest income

6,596

5,964

1,542

Interest expense

(3,348)

Gain on bargain purchase

22,049

Other income (expense), net

(1,726)

(807)

(536)

Income tax expense

(3,576)

(1,336)

(2,497)

Segment and consolidated net loss

$

(70,814)

$

(113,871)

(165,456)